A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy.
Orphanet J Rare Dis
; 17(1): 220, 2022 06 13.
Article
in En
| MEDLINE
| ID: mdl-35698080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Telangiectasia, Hereditary Hemorrhagic
Type of study:
Systematic_reviews
Aspects:
Determinantes_sociais_saude
Limits:
Humans
Language:
En
Journal:
Orphanet J Rare Dis
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: